Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
BMS-986419 by Bristol-Myers Squibb for Alzheimer's Disease: Likelihood of Approval
BMS-986419 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase...
Data Insights
BMS-986419 by Bristol-Myers Squibb for Amyotrophic Lateral Sclerosis: Likelihood of Approval
BMS-986419 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData,...